<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04932200</url>
  </required_header>
  <id_info>
    <org_study_id>WDRY2021-K061</org_study_id>
    <nct_id>NCT04932200</nct_id>
  </id_info>
  <brief_title>The Timing of Emergency Endoscopy for Esophagogastric Variceal Bleeding in Cirrhosis</brief_title>
  <official_title>A Prospective Multicenter Cohort Study on the Timing of Emergency Endoscopy for Esophagogastric Variceal Bleeding in Cirrhosis</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Renmin Hospital of Wuhan University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Beijing Friendship Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>The First Affiliated Hospital of Nanchang University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Fudan University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>The Southwest Hospital of Army Military Medical University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Beijing Shijitan Hospital, Capital Medical University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Fuyang NO.2 Renmin Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Hubei Hospital of Traditional Chinese Medicine</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Wuhan No.1 Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Wuhan Puren Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Tianyou hospital affiliated to Wuhan University of Science and Technology</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>The Central Hospital of Enshi Tujia And Miao Autonomous Prefecture</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Yichang Central People's Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Shiyan Renmin Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Wuhan Hanyang Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>The third people's Hospital of Hubei Province</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Chibi Renmin Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Renmin Hospital of Wuhan University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study is a prospective, multi-center and observational clinical study. Investigators&#xD;
      would like to explore the optimal emergency endoscopy timing in cirrhosis patients with&#xD;
      esophagogastric variceal bleeding (EGVB) by evaluating and comparing the efficacy and safety&#xD;
      of emergency endoscopy performed at different times ( within 6 hours or between 6 and 24&#xD;
      hours after gastroenterologic consultation ) and its impact on the short-term prognosis.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Between July 2021 and April 2022, patients with cirrhosis undergoing emergency endoscopy due&#xD;
      to EGVB are enrolled consecutively according to the following criteria: (1) age≥18 years; (2)&#xD;
      A definite diagnosis of cirrhosis (confirmed by medical history, laboratory examination and&#xD;
      imaging examination); (3) The cause of bleeding was identified as esophageal and/or gastric&#xD;
      vein rupture. Exclusion criteria are as follows: (1) End-stage diseases of major organs (such&#xD;
      as heart failure, chronic obstructive pulmonary disease, end-stage renal disease, and&#xD;
      malignancies other than hepatocellular carcinoma); (2) The subject (or legal&#xD;
      representative/guardian) refused to sign the informed consent.&#xD;
&#xD;
      Patients were divided into urgent-endoscopy group (&lt; 6h) and early-endoscopy group (6h-24h)&#xD;
      according to the time interval from gastroenterologic consultation to the start of emergency&#xD;
      endoscopy.&#xD;
&#xD;
      Investigators will collect patients' data of baseline character, treatment, postoperative and&#xD;
      follow-up. All patients will be followed up until death or the end of the study.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">June 15, 2021</start_date>
  <completion_date type="Anticipated">April 30, 2022</completion_date>
  <primary_completion_date type="Anticipated">April 30, 2022</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>six-week mortality rate</measure>
    <time_frame>6 weeks after treatment</time_frame>
    <description>Patients died in six weeks after emergency endoscopy due to rebleeding or other complications associated with cirrhosis.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Immediate success hemostasis rate</measure>
    <time_frame>within 24 hours after traetment</time_frame>
    <description>Successful immediate hemostasis refers to successful hemostasis under endoscopy, and no active bleeding manifestations such as hematemesis, hemorrhagic shock and progressive decline of hemoglobin within 24 hours.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>five-day rebleeding rate</measure>
    <time_frame>5 days after treatment</time_frame>
    <description>Patients rebleeded due to esophageal and gastric varices bleeding in five days after treatment.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>detection rate of bleeding site</measure>
    <time_frame>during endoscopy</time_frame>
    <description>Identify the site of bleeding during endoscopy.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>mean operating time</measure>
    <time_frame>during endoscopy</time_frame>
    <description>The time interval between the beginning and end of endoscopy.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>the needs of salvage treatment</measure>
    <time_frame>6 weeks</time_frame>
    <description>Salvage treatment refers to the additional three-chamber and two-capsule compression hemostasis, re-endoscopic therapy, interventional therapy or surgical treatment due to failure of hemostasis by emergency endoscopy or re-bleeding after successful hemostasis.</description>
  </secondary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Anticipated">608</enrollment>
  <condition>Liver Cirrhosis</condition>
  <condition>Portal Hypertension</condition>
  <condition>Esophageal Varix Bleeding</condition>
  <arm_group>
    <arm_group_label>urgent-endoscopy group</arm_group_label>
    <description>the time interval from gastroenterologic consultation to the start of emergency endoscopy &lt; 6 hours</description>
  </arm_group>
  <arm_group>
    <arm_group_label>early-endoscopy group</arm_group_label>
    <description>the time interval from gastroenterologic consultation to the start of emergency endoscopy between 6 and 24 hours</description>
  </arm_group>
  <eligibility>
    <study_pop>
      <textblock>
        Patients with cirrhosis undergoing emergency endoscopy due to EGVB are enrolled this study.&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  age≥18 years&#xD;
&#xD;
          -  A definite diagnosis of cirrhosis (confirmed by medical history, laboratory&#xD;
             examination and imaging examination)&#xD;
&#xD;
          -  The cause of bleeding was identified as esophageal and/or gastric vein rupture&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  End-stage diseases of major organs (such as heart failure, chronic obstructive&#xD;
             pulmonary disease, end-stage renal disease, and malignancies other than hepatocellular&#xD;
             carcinoma)&#xD;
&#xD;
          -  The subject (or legal representative/guardian) refused to sign the informed consent&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Mingkai Chen, PHD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Renmin Hospital of Wuhan University</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Mingkai Chen, PHD</last_name>
    <phone>+86 13720330580</phone>
    <email>kaimingchen@163.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Renmin Hospital of Wuhan University</name>
      <address>
        <city>Wuhan</city>
        <state>Hubei</state>
        <zip>430060</zip>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <reference>
    <citation>Garcia-Tsao G, Abraldes JG, Berzigotti A, Bosch J. Portal hypertensive bleeding in cirrhosis: Risk stratification, diagnosis, and management: 2016 practice guidance by the American Association for the study of liver diseases. Hepatology. 2017 Jan;65(1):310-335. doi: 10.1002/hep.28906. Epub 2016 Dec 1. Erratum in: Hepatology. 2017 Jul;66(1):304.</citation>
    <PMID>27786365</PMID>
  </reference>
  <reference>
    <citation>Tripathi D, Stanley AJ, Hayes PC, Patch D, Millson C, Mehrzad H, Austin A, Ferguson JW, Olliff SP, Hudson M, Christie JM; Clinical Services and Standards Committee of the British Society of Gastroenterology. U.K. guidelines on the management of variceal haemorrhage in cirrhotic patients. Gut. 2015 Nov;64(11):1680-704. doi: 10.1136/gutjnl-2015-309262. Epub 2015 Apr 17.</citation>
    <PMID>25887380</PMID>
  </reference>
  <reference>
    <citation>Reiberger T, Püspök A, Schoder M, Baumann-Durchschein F, Bucsics T, Datz C, Dolak W, Ferlitsch A, Finkenstedt A, Graziadei I, Hametner S, Karnel F, Krones E, Maieron A, Mandorfer M, Peck-Radosavljevic M, Rainer F, Schwabl P, Stadlbauer V, Stauber R, Tilg H, Trauner M, Zoller H, Schöfl R, Fickert P. Austrian consensus guidelines on the management and treatment of portal hypertension (Billroth III). Wien Klin Wochenschr. 2017 Nov;129(Suppl 3):135-158. doi: 10.1007/s00508-017-1262-3. Epub 2017 Oct 23.</citation>
    <PMID>29063233</PMID>
  </reference>
  <reference>
    <citation>de Franchis R; Baveno VI Faculty. Expanding consensus in portal hypertension: Report of the Baveno VI Consensus Workshop: Stratifying risk and individualizing care for portal hypertension. J Hepatol. 2015 Sep;63(3):743-52. doi: 10.1016/j.jhep.2015.05.022. Epub 2015 Jun 3.</citation>
    <PMID>26047908</PMID>
  </reference>
  <reference>
    <citation>European Association for the Study of the Liver. Electronic address: easloffice@easloffice.eu; European Association for the Study of the Liver. EASL Clinical Practice Guidelines for the management of patients with decompensated cirrhosis. J Hepatol. 2018 Aug;69(2):406-460. doi: 10.1016/j.jhep.2018.03.024. Epub 2018 Apr 10. Erratum in: J Hepatol. 2018 Nov;69(5):1207.</citation>
    <PMID>29653741</PMID>
  </reference>
  <reference>
    <citation>Cheung J, Soo I, Bastiampillai R, Zhu Q, Ma M. Urgent vs. non-urgent endoscopy in stable acute variceal bleeding. Am J Gastroenterol. 2009 May;104(5):1125-9. doi: 10.1038/ajg.2009.78. Epub 2009 Mar 31.</citation>
    <PMID>19337243</PMID>
  </reference>
  <reference>
    <citation>Hsu YC, Chung CS, Tseng CH, Lin TL, Liou JM, Wu MS, Hu FC, Wang HP. Delayed endoscopy as a risk factor for in-hospital mortality in cirrhotic patients with acute variceal hemorrhage. J Gastroenterol Hepatol. 2009 Jul;24(7):1294-9. doi: 10.1111/j.1440-1746.2009.05903.x.</citation>
    <PMID>19682197</PMID>
  </reference>
  <reference>
    <citation>Chen PH, Chen WC, Hou MC, Liu TT, Chang CJ, Liao WC, Su CW, Wang HM, Lin HC, Lee FY, Lee SD. Delayed endoscopy increases re-bleeding and mortality in patients with hematemesis and active esophageal variceal bleeding: a cohort study. J Hepatol. 2012 Dec;57(6):1207-13. doi: 10.1016/j.jhep.2012.07.038. Epub 2012 Aug 8.</citation>
    <PMID>22885718</PMID>
  </reference>
  <reference>
    <citation>Jung DH, Huh CW, Kim NJ, Kim BW. Optimal endoscopy timing in patients with acute variceal bleeding: A systematic review and meta-analysis. Sci Rep. 2020 Mar 4;10(1):4046. doi: 10.1038/s41598-020-60866-x.</citation>
    <PMID>32132589</PMID>
  </reference>
  <reference>
    <citation>Lau JYW, Yu Y, Tang RSY, Chan HCH, Yip HC, Chan SM, Luk SWY, Wong SH, Lau LHS, Lui RN, Chan TT, Mak JWY, Chan FKL, Sung JJY. Timing of Endoscopy for Acute Upper Gastrointestinal Bleeding. N Engl J Med. 2020 Apr 2;382(14):1299-1308. doi: 10.1056/NEJMoa1912484.</citation>
    <PMID>32242355</PMID>
  </reference>
  <reference>
    <citation>Huh CW, Kim JS, Jung DH, Yang JD, Nam SW, Kwon JH, Kim BW. Optimal endoscopy timing according to the severity of underlying liver disease in patients with acute variceal bleeding. Dig Liver Dis. 2019 Jul;51(7):993-998. doi: 10.1016/j.dld.2019.01.013. Epub 2019 Jan 29.</citation>
    <PMID>30803858</PMID>
  </reference>
  <verification_date>June 2021</verification_date>
  <study_first_submitted>June 11, 2021</study_first_submitted>
  <study_first_submitted_qc>June 12, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">June 21, 2021</study_first_posted>
  <last_update_submitted>June 12, 2021</last_update_submitted>
  <last_update_submitted_qc>June 12, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">June 21, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Renmin Hospital of Wuhan University</investigator_affiliation>
    <investigator_full_name>ChenMingkai</investigator_full_name>
    <investigator_title>Professor</investigator_title>
  </responsible_party>
  <keyword>esophagogastric variceal bleeding</keyword>
  <keyword>emergency endoscopy</keyword>
  <keyword>timing</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Liver Cirrhosis</mesh_term>
    <mesh_term>Hypertension, Portal</mesh_term>
    <mesh_term>Esophageal and Gastric Varices</mesh_term>
    <mesh_term>Emergencies</mesh_term>
    <mesh_term>Hemorrhage</mesh_term>
    <mesh_term>Fibrosis</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

